NIBEC Co., Ltd. (KOSDAQ:138610)
South Korea · Delayed Price · Currency is KRW 14,100
-130 (-0.91%)
At close: Jul 27, 2026
NIBEC Market Cap
NIBEC has a market cap or net worth of 151.08 billion as of July 28, 2026. Its market cap has decreased by -43.14% in one year.
Market Cap
151.08B
Enterprise Value
136.61B
Revenue
32.34B
Ranking
n/a
PE Ratio
20.70
Stock Price
14,100.00
ChartMarket Cap Chart
Since July 13, 2011, NIBEC's market cap has increased from 37.43B to 151.08B, an increase of 303.59%. That is a compound annual growth rate of 9.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 160.29B | -62.43% |
| Dec 30, 2025 | 426.64B | 145.10% |
| Dec 30, 2024 | 174.07B | -20.67% |
| Dec 28, 2023 | 219.42B | 16.28% |
| Dec 29, 2022 | 188.69B | -34.63% |
| Dec 30, 2021 | 288.67B | -32.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| S.Biomedics | 209.93B |
| Kangstem Biotech | 198.92B |
| curacle co.,ltd. | 191.31B |
| Genome & Company | 168.80B |
| Ensol Biosciences | 161.33B |
| Kanaph Therapeutics | 160.52B |
| Bio Solution | 158.70B |
| ISU Abxis | 150.26B |